Inflammation-Associated Cytotoxic Agents in Tumorigenesis

Area of Science:

• Oncology
• Cell Biology
• Biochemistry

Background:

• Chronic inflammation is intrinsically linked to all phases of cancer development.
• Inflammation involves the release of cytotoxic agents, posing a challenge for tumor cell survival.
• Tumor cells exhibit unique metabolic adaptations to counteract these cytotoxic challenges.

Purpose of the Study:

• To investigate how tumor cells overcome enhanced cytotoxic agent levels within the tumor microenvironment.
• To elucidate the interplay between cytotoxic agents and the antagonizing mechanisms employed by tumor cells.
• To focus on the disturbed balance in late-stage tumors for novel therapeutic strategies.

Main Methods:

• Review of existing literature on cellular mechanisms of tumor resistance.
• Analysis of the role of mitochondrial-derived reactive species, iron ions, and heme.
• Examination of antioxidative enzymes, protective proteins, and redox homeostasis maintenance.

Main Results:

• Tumor cells overexpress antioxidative enzymes and proteins to maintain redox homeostasis.
• These mechanisms enable tumor cells to withstand additional stress from radio- and chemotherapy.
• Tumor cells secrete agents that suppress immune cells and promote extracellular matrix formation, aiding invasion and metastasis.

Conclusions:

• Tumor cells possess sophisticated defense systems to counteract cytotoxic agents, crucial for survival and progression.
• The disturbed balance between cytotoxic agents and protective mechanisms in late-stage tumors is a key therapeutic target.
• Understanding these interactions is essential for developing innovative anti-cancer therapies.